首页> 美国卫生研究院文献>Annals of Pediatric Endocrinology Metabolism >Type 2 diabetes mellitus in children and adolescent: an Indonesian perspective
【2h】

Type 2 diabetes mellitus in children and adolescent: an Indonesian perspective

机译:儿童和青少年的2型糖尿病:印度尼西亚的观点

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The prevalence of type 2 diabetes mellitus (T2DM) in children and adolescents has increased globally over the past 2 decades. Metabolic syndrome, including obesity and overweight at a young age, increases the occurrence of T2DM. Studies in Indonesia have found that obese children and adolescents are more likely to have insulin resistance, a risk factor for T2DM. There are no data on the current incidence of T2DM in youth in Indonesia, but there has been a significant rise in the prevalence of overweight in adolescents. The diagnosis of T2DM in youth is similar to that in adults, with special consideration of when to test asymptomatic children. Management of T2DM in Indonesia follows the recommendations of the Indonesian Pediatric Society, which include lifestyle modifications, such as improving dietary habits and exercise, as well as appropriate medications. Metformin is the drug of choice for young T2DM patients; if marked hyperglycemia is present, basal insulin is given with metformin. Monitoring of T2DM is generally done through selfmonitoring of blood glucose and glycosylated hemoglobin.
机译:在过去的20年中,儿童和青少年的2型糖尿病(T2DM)患病率在全球范围内呈上升趋势。代谢综合征(包括肥胖和年轻时超重)增加了T2DM的发生。印度尼西亚的研究发现,肥胖的儿童和青少年更容易产生胰岛素抵抗,这是T2DM的危险因素。目前尚无关于印度尼西亚年轻人中T2DM发病率的数据,但青少年超重率普遍上升。青年时期T2DM的诊断与成人相似,特别考虑何时对无症状儿童进行检查。在印度尼西亚,T2DM的管理遵循印度尼西亚儿科学会的建议,其中包括改变生活方式,例如改善饮食习惯和运动以及适当的药物治疗。二甲双胍是年轻T2DM患者的首选药物;如果存在明显的高血糖症,则将基础胰岛素与二甲双胍一起给予。通常通过自我监测血糖和糖基化血红蛋白来监测T2DM。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号